𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer

✍ Scribed by Yoshimasa Kitagawa; Sadahiko Nishizawa; Kazuo Sano; Norihiro Sadato; Yoshihiro Maruta; Toshiyuki Ogasawara; Mikiko Nakamura; Yoshiharu Yonekura

Book ID
117846787
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
147 KB
Volume
93
Category
Article
ISSN
1528-395X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical value of whole-body positron em
Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer
✍ G. Beets; Professor F. Penninckx; C. Schiepers; L. Filez; L. Mortelmans; R. Kerr πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 587 KB

## Abstract To assess the clinical value of whole-body positron emission tomography (PET) with [18F]fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had resectable liver metastases, one a resectable lung metastasis, eight resectable pelvic recurrence, eight a pr

Evaluation of chemotherapy response in p
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography
✍ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m